Lead Product(s) : Colostrum
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Clinical Proof-of-concept Study on Rapid Immune Modulating Effects
Details : Colostrum is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
May 06, 2022
Lead Product(s) : Colostrum
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Colostrum
Therapeutic Area : Gastroenterology
Study Phase : Phase II/ Phase III
Sponsor : Cell Biotech Co., Ltd.
Deal Size : Inapplicable
Deal Type : Inapplicable
Effect of Colostrum on Gut Permeability and Endotoxin Level in Chronic Alcoholic Disease
Details : Colostrum is a Dietary Supplement drug candidate, which is currently being evaluated in phase II/ phase III clinical studies for the treatment of Leaky Gut Syndrome.
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
March 17, 2010
Lead Product(s) : Colostrum
Therapeutic Area : Gastroenterology
Highest Development Status : Phase II/ Phase III
Sponsor : Cell Biotech Co., Ltd.
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
